# US 2018/0023057 A1 · Cell culture method, cell aggregates, cell aggregation control agent, and medium

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2018/0023057 A1
- Document ID: US20180023057A1
- Status: Published application
- Kind: A1
- Application number: 15/547,316
- Filed: 2016-01-27
- Published: 2018-01-25
- Earliest claimed: 2015-01-29
- Assignees: The University of Tokyo; Somar Corporation
- Applicants: The University of Tokyo; Somar Corporation
- Inventors: Yasuyuki SAKAI; Ikki HORIGUCHI; Kumiko MATSUNAGA; Shunji HAYASAKA
- Web page: https://patentgrep.com/patent/US20180023057A1

## CPC

- C12N 5/0696: {Artificially induced pluripotent stem cells, e.g. iPS}
- C07K 2/00: Peptides of undefined number of amino acids; Derivatives thereof
- C07K 14/705: Receptors; Cell surface antigens; Cell surface determinants {(tumour specific antigens C07K14/4748)}
- C07K 14/70596: {Molecules with a "CD"-designation not provided for elsewhere}
- C07K 14/78: Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
- C07K 16/18: against material from animals or humans
- C07K 19/00: Hybrid peptides {, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes}
- C12N 5/10: Cells modified by introduction of foreign genetic material
- C07K 2319/30: Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
- C12N 2501/58: Adhesion molecules, e.g. ICAM, VCAM, CD18 (ligand), CD11 (ligand), CD49 (ligand)
- C12N 2501/599: with CD designations not provided for elsewhere
- C12N 2513/00: 3D culture
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

A method for culturing cells by which the diameter of cell aggregates can be controlled, and by which a large amount of cells can be obtained, a cell aggregate obtained by the method, a cell aggregation control agent, and a medium containing the cell aggregation control agent, are provided. A method for culturing cells by suspension culture, which method includes an aggregation control step of adding a substance that inhibits a cell adhesion molecule(s) of the cells to a medium to control cell aggregation of the cells, and the like are provided.

## Claims

### Claim 1

A method for culturing cells by suspension culture, said method comprising an aggregation control step of adding a substance that inhibits a cell adhesion molecule(s) of said cells to a medium to control cell aggregation of said cells.

### Claim 2 (depends on 1)

The culture method according to claim 1, wherein, in said aggregation control step, said substance that inhibits a cell adhesion molecule(s) is added to said medium at a concentration of 10 to 50 μg/ml.

### Claim 3 (depends on 1)

The culture method according to claim 1, wherein said substance that inhibits a cell adhesion molecule(s) is at least one selected from cell adhesion molecules, proteins composed of partial regions of cell adhesion molecules, fusion proteins containing the whole or partial regions of cell adhesion molecules, neutralizing antibodies against cell adhesion molecules, peptides that bind to cell adhesion molecules, and derivatives thereof.

### Claim 4 (depends on 1)

The culture method according to claim 1, wherein said substance that inhibits a cell adhesion molecule(s) contains at least one selected from E-cadherin, proteins composed of partial regions of E-cadherin, fusion proteins containing the whole or a partial region of E-cadherin, neutralizing antibodies against E-cadherin, peptides that bind to E-cadherin, and derivatives thereof.

### Claim 5 (depends on 1)

The culture method according to claim 1, wherein said cells are stem cells or epithelial cells.

### Claim 6 (depends on 1)

An aggregate of said cells obtained by the culture method according to claim 1, having a uniform aggregation diameter.

### Claim 7 (depends on 6)

The aggregate according to claim 6, wherein the diameter of said aggregate after 48 hours of suspension culture is not less than 20 μm and less than 1 mm.

### Claim 8

A cell aggregation control agent comprising a substance that inhibits a cell adhesion molecule(s).

### Claim 9 (depends on 8)

The cell aggregation control agent according to claim 8, comprising, as said substance that inhibits a cell adhesion molecule(s), at least one selected from E-cadherin, proteins composed of partial regions of E-cadherin, fusion proteins containing the whole or a partial region of E-cadherin, neutralizing antibodies against E-cadherin, peptides that bind to E-cadherin, and derivatives thereof.

### Claim 10 (depends on 9)

The cell aggregation control agent according to claim 9, wherein said peptide that binds to E-cadherin is a peptide composed of the amino acid sequence of SEQ ID NO: 3.

### Claim 11 (depends on 8)

A medium containing the cell aggregation control agent according to any claim 8.

### Claim 12 (depends on 2)

The culture method according to claim 2, wherein said cells are stem cells or epithelial cells.

### Claim 13 (depends on 3)

The culture method according to claim 3, wherein said cells are stem cells or epithelial cells.

### Claim 14 (depends on 4)

The culture method according to claim 4, wherein said cells are stem cells or epithelial cells.

### Claim 15 (depends on 9)

A medium containing the cell aggregation control agent according to claim 9.

### Claim 16 (depends on 10)

A medium containing the cell aggregation control agent according to claim 10.
